125 related articles for article (PubMed ID: 34446385)
1. Testicular metastasis of prostate origin diagnosed by PET/MR with
Garcia JR; Compte A; Bassa P; Soler M; Buxeda M; Riera E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 Aug; ():. PubMed ID: 34446385
[No Abstract] [Full Text] [Related]
2. Testicular metastasis of prostate origin diagnosed by PET/MR with
Garcia JR; Compte A; Bassa P; Soler M; Buxeda M; Riera E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(1):51-52. PubMed ID: 35637149
[No Abstract] [Full Text] [Related]
3. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment
Kjölhede H; Almquist H; Lyttkens K; Bratt O
Eur J Hybrid Imaging; 2018; 2(1):16. PubMed ID: 30148254
[TBL] [Abstract][Full Text] [Related]
5. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
6.
Garcia JR; Compte A; Galan C; Cozar M; Buxeda M; Mourelo S; Piñeiro T; Soler M; Valls E; Bassa P; Santabarbara JM
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(2):72-81. PubMed ID: 33579662
[TBL] [Abstract][Full Text] [Related]
7. 18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
Urso L; Lancia F; Ortolan N; Frapoli M; Rauso M; Artioli P; Cittanti C; Uccelli L; Frassoldati A; Evangelista L; Bartolomei M
Clin Transl Imaging; 2022; 10(6):687-695. PubMed ID: 35919380
[TBL] [Abstract][Full Text] [Related]
8. Value of
García JR; Compte A; Buxeda M; Mourelo S; Soler M; Blanch A; Valls E; Riera E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):197-203. PubMed ID: 32165153
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Choline-based imaging of prostate cancer with combined [
Wetter A; Grüneisen J; Fliessbach K; Lütje S; Schaarschmidt B; Umutlu L
Clin Imaging; 2017; 42():198-202. PubMed ID: 28110202
[TBL] [Abstract][Full Text] [Related]
11. Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates.
Krause BJ; Souvatzoglou M; Treiber U
Urol Oncol; 2013 May; 31(4):427-35. PubMed ID: 21388835
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of tumor segmentation from multi-parametric prostate MRI and
Piert M; Shankar PR; Montgomery J; Kunju LP; Rogers V; Siddiqui J; Rajendiran T; Hearn J; George A; Shao X; Davenport MS
EJNMMI Res; 2018 Mar; 8(1):23. PubMed ID: 29589155
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility and therapeutic impact of PET/CT [
Sánchez N; Valduvieco I; Ribal MJ; Campos F; Casas F; Nicolau C; Salvador R; Mellado B; Jorcano S; Fuster D; Paredes P
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):284-291. PubMed ID: 32467000
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy.
Yamaguchi T; Lee J; Uemura H; Sasaki T; Takahashi N; Oka T; Shizukuishi K; Endou H; Kubota Y; Inoue T
Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):742-8. PubMed ID: 16052370
[TBL] [Abstract][Full Text] [Related]
15. Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.
Watanabe H; Kanematsu M; Kondo H; Kako N; Yamamoto N; Yamada T; Goshima S; Hoshi H; Bae KT
J Magn Reson Imaging; 2010 May; 31(5):1151-6. PubMed ID: 20432351
[TBL] [Abstract][Full Text] [Related]
16. Role of
Jiménez Londoño GA; García Vicente AM; Amo-Salas M; Fúnez Mayorga F; López Guerrero MA; Talavera Rubio MP; Gutierrez Martin P; González García B; de la Torre Pérez JA; Soriano Castrejón ÁM
Rev Esp Med Nucl Imagen Mol; 2017; 36(4):241-246. PubMed ID: 28330596
[TBL] [Abstract][Full Text] [Related]
17. Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
Sollini M; Pasqualetti F; Perri M; Coraggio G; Castellucci P; Roncali M; Boni R; Lazzeri E; Galeandro M; Paiar F; Versari A; Erba PA
Cancer Imaging; 2016 Aug; 16(1):27. PubMed ID: 27581366
[TBL] [Abstract][Full Text] [Related]
18. Detection Rate of
Jilg CA; Drendel V; Rischke HC; Beck TI; Reichel K; Krönig M; Wetterauer U; Schultze-Seemann W; Meyer PT; Vach W
J Nucl Med; 2019 Jul; 60(7):971-977. PubMed ID: 30683768
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results.
Nanni C; Schiavina R; Boschi S; Ambrosini V; Pettinato C; Brunocilla E; Martorana G; Fanti S
Eur J Nucl Med Mol Imaging; 2013 Jul; 40 Suppl 1():S11-7. PubMed ID: 23591953
[TBL] [Abstract][Full Text] [Related]
20. Metastasis-directed Therapy (SBRT) Guided by PET-CT
Mazzola R; Francolini G; Triggiani L; Napoli G; Cuccia F; Nicosia L; Livi L; Magrini SM; Salgarello M; Alongi F
Clin Genitourin Cancer; 2021 Jun; 19(3):230-236. PubMed ID: 32863189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
